Zoledronate and periodontal disease Patient Reports February 12, 2012

Zoledronate Side Effects Report #4819353-5
Zoledronate side effect was reported by a Health Professional from ITALY on Oct 20, 2005. Male patient, 67 years of age, was diagnosed with prostate cancer  and was treated with Zoledronate. After drug was administered, patient experienced the following side effects: bone debridement, bone disorder, bone pain, osteomyelitis, osteomyelitis chronic, osteonecrosis , periodontal disease, primary sequestrum, sequestrectomy. Zoledronate dosage: unknown. During the same period patient was treated with EPIRUBICIN, ANTIANDROGENS. Patient recovered.

Zoledronate Side Effects Report #4819388-2
Zoledronate side effect was reported by a Health Professional from ITALY on Oct 20, 2005. Male patient, 67 years of age, was diagnosed with prostate cancer  and was treated with Zoledronate. After drug was administered, patient experienced the following side effects: bone debridement, bone disorder, bone pain, jaw disorder, osteomyelitis, osteomyelitis chronic, osteonecrosis , periodontal disease, primary sequestrum. Zoledronate dosage: unknown. During the same period patient was treated with EPIRUBICIN, ANTIANDROGENS. Patient recovered.

Zoledronate Side Effects Report #4819351-1
Zoledronate side effect was reported by a Health Professional from ITALY on Oct 20, 2005. Male patient, 76 years of age, was diagnosed with multiple myeloma  and was treated with Zoledronate. After drug was administered, patient experienced the following side effects: bone debridement, bone disorder, bone pain, osteomyelitis, osteonecrosis , periodontal disease, primary sequestrum, sequestrectomy, tooth extraction. Zoledronate dosage: unknown. During the same period patient was treated with PREDNISONE, MELPHALAN. Patient recovered.

Zoledronate Side Effects Report #4819354-7
Zoledronate side effect was reported by a Health Professional from ITALY on Oct 20, 2005. Female patient, 69 years of age, was diagnosed with multiple myeloma  and was treated with Zoledronate. After drug was administered, patient experienced the following side effects: bone debridement, bone disorder, bone pain, osteomyelitis, osteomyelitis chronic, osteonecrosis , periodontal disease, primary sequestrum, sequestrectomy. Zoledronate dosage: unknown. During the same period patient was treated with MELPHALAN, BONE MARROW TRANSPLANT, PREDNISONE. Patient recovered.


Zoledronate Side Effects Report #5947470-5
Zoledronate side effect was reported by a Physician from UNITED KINGDOM on Oct 29, 2008. Male patient, weighting 147.7 lb, was diagnosed with metastases to bone and was treated with Zoledronate. After drug was administered, patient experienced the following side effects: gingival infection, impaired healing, osteonecrosis , pain , periodontal disease, primary sequestrum, tooth extraction, tooth injury. Zoledronate dosage: 4 MG,. During the same period patient was treated with CELECOXIB, HORMONES, VITAMIN D, CALCIUM. Patient recovered.

Zoledronate Side Effects Report #4819341-9
Zoledronate side effect was reported by a Health Professional from ITALY on Oct 20, 2005. Male patient, 60 years of age, was diagnosed with lung neoplasm malignant and was treated with Zoledronate. After drug was administered, patient experienced the following side effects: bone debridement, bone disorder, bone pain, osteomyelitis, osteomyelitis chronic, osteonecrosis , periodontal disease, primary sequestrum, sequestrectomy. Zoledronate dosage: unknown. Patient recovered.

Zoledronate Side Effects Report #4819352-3
Zoledronate side effect was reported by a Health Professional from ITALY on Oct 20, 2005. Female patient, 48 years of age, was diagnosed with breast cancer  and was treated with Zoledronate. After drug was administered, patient experienced the following side effects: bone debridement, bone disorder, bone pain, osteomyelitis, osteomyelitis chronic, osteonecrosis , periodontal disease, primary sequestrum, sequestrectomy. Zoledronate dosage: unknown. During the same period patient was treated with EXEMESTANE, CAPECITABINE, TRASTUZUMAB, CYCLOPHOSPHAMIDE, PACLITAXEL, VINORELBINE. Patient recovered.